Page 138 - GPD-4-2

Gene & Protein in Disease Binding of 11q to DENV and WNV proteases

Consent for publication of flaviviruses contains an RNA triphosphatase activity.
Virology. 1993;197(1):265-273.
Not applicable.
doi: 10.1006/viro.1993.1587
Availability of data 11. Apte-Sengupta S, Sirohi D, Kuhn RJ. Coupling of

All the data are provided in the manuscript. Raw files can replication and assembly in flaviviruses. Curr Opin Virol.
be obtained from the corresponding author on request. 2014;9:134-142.
doi: 10.1016/j.coviro.2014.09.020
References
12. Noble CG, Seh CC, Chao AT, Shi PY. Ligand-bound
1. Malavige G, Fernando S, Fernando DJ, Seneviratne SL. structures of the dengue virus protease reveal the active
Dengue viral infections. Postgrad Med J. 2004;80(948): conformation. J Virol. 2012;86(1):438-446.
588-601.
doi: 10.1128/JVI.06225-11
doi: 10.1136/pgmj.2004.019638
13. Erbel P, Schiering N, D’Arcy A, et al. Structural basis for the
2. Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966): activation of flaviviral NS3 proteases from dengue and West
453-465. nile virus. Nat Struct Mol Biol. 2006;13(4):372-373.
doi: 10.1016/S0140-6736(14)60572-9 doi: 10.1038/nsmb1073
3. Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, 14. Luo D, Vasudevan SG, Lescar J. The flavivirus NS2B-NS3
Wong TAS, Margosiak SA. Small molecule pan-dengue protease-helicase as a target for antiviral drug development.
and west nile virus NS3 protease inhibitors. Antivir Chem Antivir Res. 2015;118:148-158.
Chemother. 2011;21(5):209-218.
doi: 10.1016/j.antiviral.2015.03.014
doi: 10.3851/IMP1767
15. Purohit P, Sahoo S, Panda M, Sahoo PS, Meher BR. Targeting
4. Bhatt S, Gething PW, Brady OJ, et al. The global distribution the DENV NS2B-NS3 protease with active antiviral
and burden of dengue. Nature. 2013;496(7446):504-507. phytocompounds: Structure-based virtual screening,
doi: 10.1038/nature12060 molecular docking and molecular dynamics simulation
studies. J Mol Model. 2022;28(11):365.
5. Lim SP, Shi PY. West nile virus drug discovery. Viruses.
2013;5(12):2977-3006. doi: 10.1007/s00894-022-05355-w
doi: 10.3390/v5122977 16. Chakraborty T, Alcamo IE. Dengue Fever and Other
Hemorrhagic Viruses. New York: Infobase Publishing; 2008.
6. Petersen LR, Brault AC, Nasci RS. West nile virus: Review of
the literature. JAMA. 2013;310(3):308-315. 17. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus
genome organization, expression, and replication. Annu Rev
doi: 10.1001/jama.2013.8042 Microbiol. 1990;44:649-688.
7. Li J, Lim SP, Beer D, et al. Functional profiling of recombinant doi: 10.1146/annurev.mi.44.100190.003245
NS3 proteases from all four serotypes of dengue virus using
tetrapeptide and octapeptide substrate libraries. J Biol Chem. 18. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West
2005;280(31):28766-28774. nile virus: Biology, transmission, and human infection. Clin
Microbiol Rev. 2012;25(4):635-648.
doi: 10.1074/jbc.M500588200
doi: 10.1128/CMR.00045-12
8. Yusof R, Clum S, Wetzel M, Murthy HK, Padmanabhan R.
Purified NS2B/NS3 serine protease of dengue virus 19. Lei J, Hansen G, Nitsche C, Klein CD, Zhang L,
type 2 exhibits cofactor NS2B dependence for cleavage of Hilgenfeld R. Crystal structure of Zika virus NS2B-NS3
substrates with dibasic amino acids in vitro. J Biol Chem. protease in complex with a boronate inhibitor. Science.
2000;275(14):9963-9969. 2016;353(6298):503-505.
doi: 10.1074/jbc.275.14.9963 doi: 10.1126/science.aag2419
9. Lima AB, Behnam MA, El Sherif Y, Nitsche C, Vechi SM, 20. Zhang Z, Li Y, Loh YR, et al. Crystal structure of
Klein CD. Dual inhibitors of the dengue and West Nile virus unlinked NS2B-NS3 protease from Zika virus. Science.
NS2B-NS3 proteases: Synthesis, biological evaluation and 2016;354(6319):1597-1600.
docking studies of novel peptide-hybrids. Bioorg Med Chem. doi: 10.1126/science.aai9309
2015;23(17):5748-5755.
21. Pant S, Jena NR. C-terminal extended hexapeptides as
doi: 10.1016/j.bmc.2015.07.012
potent inhibitors of the NS2B-NS3 protease of the ZIKA
10. Wengler G, Wengler G. The NS 3 nonstructural protein virus. Front Med. 2022;9:921060.

Volume 4 Issue 2 (2025) 9 doi: 10.36922/gpd.8293